Press "Enter" to skip to content

Factbox: Bayer faces lengthy Roundup appeals and settlement talks continue

Bayer AG’s shares have taken a hit since three consecutive U.S. juries awarded more than $2 billion in damages to cancer patients alleging that the company’s glyphosate-based weed killer, Roundup, caused their disease.

Source:: Breaking News

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *